Navigation Links
Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
Date:9/12/2007

ACTON, Mass., Sept. 12 /PRNewswire-FirstCall/ -- Psychemedics Corporation (Amex: PMD) was selected to participate in and co-sponsor Chief Talent Officer, an innovative new book sponsored by Accenture that addresses human resource management issues and the growing imperative for HR leaders to become chief talent officers.

Chief Talent Officer showcases chief executive officers and human resource executives who have demonstrated innovative approaches to leading and managing human capital to drive high performance. The publication also presents insights on human capital and workforce performance from key senior executives within Accenture's Human Performance practice, other industry leaders and academia. The book describes a number of proven practices for strategic leadership of the HR function that executives can implement in their organizations today.

Ultimately, organizations that are leaders in managing talent have executives at their helms that elevate human performance initiatives to a strategic corporate platform. These chief talent officers are the driving forces that transform their organizations' workforces.

Chief Talent Officer profiles a number of leaders from companies including Sara Lee Corporation, Unilever, Royal Dutch Shell, AstraZeneca and AT&T that have "cracked the code" and adopted highly effective human capital management philosophies and practices that drive competitive advantage. Through specially commissioned interviews with these leaders, the book reveals best practices for strategic leadership of the HR function and demonstrates how successful chief talent officers have brought the workforce to the forefront of the executive agendas for their organizations.

Raymond C. Kubacki, Chairman and CEO of Psychemedics, is one of the leaders profiled in the book. "We work with HR executives every day of the week on how to reduce risk, including making sure that human assets don't become a liability," he states in the book. "We have a very large number of clients who are consistently addressing employee risk factors and understand how important those decisions are in creating a top-notch workforce and a positive workplace environment."

"Chief Talent Officer is very innovative," said Kubacki. "As HR executives undertake the journey to chief talent officers, the top human resource executive needs to become the chief talent officer and many companies are already in that mode to drive performance. Full implementation of this successful platform, however, is also dependent upon the CEO recognizing the significance of this CTO position and clearly establishing its importance within the whole organization."

The book will be distributed to CEO's and top HR professionals within Accenture's client organizations in the US and internationally. Total distribution will be 20,000.

About Psychemedics

Psychemedics is the world's largest provider of hair testing for drugs of abuse with thousands of corporations relying on the patented Psychemedics drug testing services. Psychemedics' clients include over 10% of the Fortune 500, some of the largest police departments in America and Federal Reserve Banks.

The Psychemedics web site is http://www.drugtestwithhair.com

Contact:

Raymond C. Kubacki

Chairman and CEO, Psychemedics Corporation

978-206-8220

Cautionary Statement for purposes of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995: From time to time, information provided by Psychemedics may contain forward-looking information that involves risks and uncertainties. In particular, statements contained in this release that are not historical facts (including but not limited to statements concerning growth, earnings, profit margins, earnings per share, revenues, dividends, future business, new accounts, customer base, market share, test volume and sales and marketing strategies) may be "forward looking" statements. Actual results may differ from those stated in any forward-looking statements. Factors that may cause such differences include but are not limited to risks associated with the expansion of the Company's sales and marketing network, development of markets for new products and services offered, the economic health of principal customers of the Company, government regulation, including but not limited to FDA regulations, competition and general economic conditions and other factors disclosed in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Psychemedics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
2. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
3. Rat joins list of cloned animals
4. Richard Gere Joins Indian Stars For Fight Against AIDS
5. Enbrel Joins with Methotrexate to Cure Rheumatoid Arthritis
6. Anoushka Joins Hands With WFP to Feed the Poor
7. India Joins Hands With Global Body for Vaccine Research
8. Another Statewide Organization Joins the Fight Against Assisted Suicide
9. Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius
10. Innovative device aids in advanced heart failure
11. Innovative footwear may prevent fall in elderly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... La. (PRWEB) , ... February 18, 2017 , ... ... released today provides the latest information and contact points to easily connect elderly ... home care, assisted living, and elder-care funding. It also conveys material on this ...
(Date:2/17/2017)... Murfreesboro, TN (PRWEB) , ... February 17, 2017 ... ... EHR mobility has not kept pace. Enovate Medical has introduced an innovative workstation ... 20 years of supporting nurses, the Encore Mobile EHR Workstation offers a lightweight, ...
(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... software tools that allow for the electronic prescribing of controlled and non-controlled substances ... , Ninety percent of pharmacies in the United States now accept electronic prescriptions, ...
(Date:2/17/2017)... Falls Church, VA (PRWEB) , ... ... ... to Integrate FDA Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. ... , What are the critical reimbursement questions manufacturers should be asking ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... to Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, 2017 — 1:30 ... manufacturers distinguish between corrective action (CA) and preventive action (PA)? , The methods ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... TOWN, South Africa , Feb. 20, 2017 /PRNewswire/ ... of illness and non-communicable diseases (NCDs) across sub-Saharan Africa, ... prescription drugs. The growing incidence of more Western lifestyle ... respiratory disease, in addition to infectious and parasitic illness, ... with a business opportunity of $40.8 billion ...
(Date:2/20/2017)... SAN FRANCISCO , February 20, 2017 /PRNewswire/ ... (CSF) management market  is anticipated to reach USD ... report by Grand View Research, Inc. Constant evaluation ... hydrocephalus management is expected to drive growth in ... the investment for development of novel and improved ...
(Date:2/20/2017)... 20, 2017 Acute, Chronic and Prophylaxis GVHD ... at a CAGR of 7% from 2016-2021 and CAGR of 3% from ... from 2016 to 2027. The market is estimated at $0.36bn in 2016, ... ... discover how you can exploit the future business opportunities emerging in this ...
Breaking Medicine Technology: